A personalized health platform providing comprehensive blood testing and AI-driven insights for longevity.
Function Health is a personalized health platform that provides users with access to over 100 comprehensive biomarker tests and AI-powered medical insights. The company focuses on preventative care and longevity, allowing individuals to track their health data over time and make informed decisions about their well-being.
Healthcare📍 Austin, TXFounded 2022
Current Valuation
$2.5B
as of 2025-Q4
UNICORN
QL Price
$2.5B
0% vs last round
QuantLogix's current estimate for Function Health, published 2026-09-09 — in line with the last disclosed round of $2.5B (2025-Q4).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$2.5B
2025-Q4
weight 0.62
Secondary market print
$2.5B
2026-06-27
weight 0.64
How this price has held up
No round has priced for Function Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-09 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Function Health, 2026-09-09 (705269c22bead5bd).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Function Health going public?
No. Function Health is private and has not filed to go public. There is no S-1 on file.
What is Function Health's valuation in 2026?
Function Health is valued at $2.5B as of 2025-Q4, set by its Series B ($298M, Nov 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Function Health filed an S-1?
No public S-1 is on file for Function Health.
Who are Function Health's investors?
Function Health's investors include Redpoint Ventures, Andreessen Horowitz, Founders Fund, Redesign Health, Aglaé Ventures, SV Angel and 2 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Jonathan Swerdlin
Founded
2022
HQ
Austin, TX
Employees
~470
Total Raised
$351M
Est. Revenue
$50M (2025)
Growth
426% revenue growth in 2025
Last Round
Series B — $298M (Nov 2025) · Lead: Redpoint Ventures
IPO Status
private
Fundraising Status
Series B · $298M · 10 mo ago
privateTotal raised $351M
Secondary Market
Implied price / share
$60
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B
$298M
Nov 2025
Redpoint Ventures
—
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
5
via careers page
Product-build share
20%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 20% of open roles build product — hiring is concentrated in sales/marketing/ops (3 of 5 open roles are operations).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
[Testing locations](https://www.functionhealth.com/lab-locations)What people sayRemote-first workplaceOpen time-off policy[What people say](https://www.functionhealth.com/what-people-say)
Counted from Function Health's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Mark HymanJonathan SwerdlinPranitha PatilMike NemkeSeth WeisfeldDaniel Swerdlin
Investors
Redpoint Ventures · Andreessen Horowitz · Founders Fund · Redesign Health · Aglaé Ventures · SV Angel · FirstMark · K2 Global
LongevityHealth TechDiagnosticsAIPersonalized Medicine
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q4. Refreshed quarterly.